Effects of psychosensory stimulation on anal pressures

Effects of alfuzosin

Anjani Muthyala, Kelly J. Feuerhak, William S. Harmsen, Subhankar Chakraborty, Kent R. Bailey, Adil Eddie Bharucha

Research output: Contribution to journalArticle

Abstract

Background: Our aim is to explain the lack of clarity in the ways in which anxiety and depression, which are common in defecatory disorders (DD), may contribute to the disorder. In this study, we evaluate the effects of mental stress and relaxation on anal pressures and the mechanisms thereof. Methods: In 38 healthy women and 36 DD patients, rectoanal pressures were assessed at rest and during mental stressors (ie, word-color conflict [Stroop] and mental arithmetic tests) and mental relaxation, before and after randomization to placebo or the adrenergic α 1 -antagonist alfuzosin. Key Results: During the baseline Stroop test, the anal pressure increased by 6 ± 13 mm Hg (mean ± SD, P = 0.004) in healthy women and 9 ± 10 mm Hg (P = 0.0001) in constipated women. During mental arithmetic, the anal pressure increased in healthy (4 ± 8 mm Hg, P = 0.002) and constipated women (5 ± 9 mm Hg, P = 0.004). After relaxation, anal pressure declined (P = 0.0004) by 3 ± 4 mm Hg in DD patients but not in controls. Alfuzosin reduced (P = 0.0001) anal resting pressure (by 31 ± 19 mm Hg) vs placebo (16 ± 18 mm Hg). However, during the postdrug Stroop test, anal pressure increased (P = 0.0001) in participants who received alfuzosin but not placebo. Conclusions & Inferences: In healthy controls and DD patients, mental stressors likely increased anal pressure by contracting the internal anal sphincter; relaxation reduced anal pressure in DD patients. Alfuzosin reduced anal resting pressure but did not block the Stroop-mediated contractile response, which suggests that this response is not entirely mediated by adrenergic α 1 receptors.

Original languageEnglish (US)
Article numbere13618
JournalNeurogastroenterology and Motility
DOIs
StatePublished - Jan 1 2019

Fingerprint

Pressure
Stroop Test
Placebos
alfuzosin
Intelligence Tests
Adrenergic Antagonists
Mentally Ill Persons
Anal Canal
Random Allocation
Mental Disorders
Adrenergic Receptors
Anxiety
Color
Depression

Keywords

  • alfuzosin
  • anal pressure
  • constipation
  • mental stressors
  • Stroop

ASJC Scopus subject areas

  • Physiology
  • Endocrine and Autonomic Systems
  • Gastroenterology

Cite this

Effects of psychosensory stimulation on anal pressures : Effects of alfuzosin. / Muthyala, Anjani; Feuerhak, Kelly J.; Harmsen, William S.; Chakraborty, Subhankar; Bailey, Kent R.; Bharucha, Adil Eddie.

In: Neurogastroenterology and Motility, 01.01.2019.

Research output: Contribution to journalArticle

Muthyala, Anjani ; Feuerhak, Kelly J. ; Harmsen, William S. ; Chakraborty, Subhankar ; Bailey, Kent R. ; Bharucha, Adil Eddie. / Effects of psychosensory stimulation on anal pressures : Effects of alfuzosin. In: Neurogastroenterology and Motility. 2019.
@article{d78346291baf4e71b4c21c5eda679169,
title = "Effects of psychosensory stimulation on anal pressures: Effects of alfuzosin",
abstract = "Background: Our aim is to explain the lack of clarity in the ways in which anxiety and depression, which are common in defecatory disorders (DD), may contribute to the disorder. In this study, we evaluate the effects of mental stress and relaxation on anal pressures and the mechanisms thereof. Methods: In 38 healthy women and 36 DD patients, rectoanal pressures were assessed at rest and during mental stressors (ie, word-color conflict [Stroop] and mental arithmetic tests) and mental relaxation, before and after randomization to placebo or the adrenergic α 1 -antagonist alfuzosin. Key Results: During the baseline Stroop test, the anal pressure increased by 6 ± 13 mm Hg (mean ± SD, P = 0.004) in healthy women and 9 ± 10 mm Hg (P = 0.0001) in constipated women. During mental arithmetic, the anal pressure increased in healthy (4 ± 8 mm Hg, P = 0.002) and constipated women (5 ± 9 mm Hg, P = 0.004). After relaxation, anal pressure declined (P = 0.0004) by 3 ± 4 mm Hg in DD patients but not in controls. Alfuzosin reduced (P = 0.0001) anal resting pressure (by 31 ± 19 mm Hg) vs placebo (16 ± 18 mm Hg). However, during the postdrug Stroop test, anal pressure increased (P = 0.0001) in participants who received alfuzosin but not placebo. Conclusions & Inferences: In healthy controls and DD patients, mental stressors likely increased anal pressure by contracting the internal anal sphincter; relaxation reduced anal pressure in DD patients. Alfuzosin reduced anal resting pressure but did not block the Stroop-mediated contractile response, which suggests that this response is not entirely mediated by adrenergic α 1 receptors.",
keywords = "alfuzosin, anal pressure, constipation, mental stressors, Stroop",
author = "Anjani Muthyala and Feuerhak, {Kelly J.} and Harmsen, {William S.} and Subhankar Chakraborty and Bailey, {Kent R.} and Bharucha, {Adil Eddie}",
year = "2019",
month = "1",
day = "1",
doi = "10.1111/nmo.13618",
language = "English (US)",
journal = "Neurogastroenterology and Motility",
issn = "1350-1925",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Effects of psychosensory stimulation on anal pressures

T2 - Effects of alfuzosin

AU - Muthyala, Anjani

AU - Feuerhak, Kelly J.

AU - Harmsen, William S.

AU - Chakraborty, Subhankar

AU - Bailey, Kent R.

AU - Bharucha, Adil Eddie

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Background: Our aim is to explain the lack of clarity in the ways in which anxiety and depression, which are common in defecatory disorders (DD), may contribute to the disorder. In this study, we evaluate the effects of mental stress and relaxation on anal pressures and the mechanisms thereof. Methods: In 38 healthy women and 36 DD patients, rectoanal pressures were assessed at rest and during mental stressors (ie, word-color conflict [Stroop] and mental arithmetic tests) and mental relaxation, before and after randomization to placebo or the adrenergic α 1 -antagonist alfuzosin. Key Results: During the baseline Stroop test, the anal pressure increased by 6 ± 13 mm Hg (mean ± SD, P = 0.004) in healthy women and 9 ± 10 mm Hg (P = 0.0001) in constipated women. During mental arithmetic, the anal pressure increased in healthy (4 ± 8 mm Hg, P = 0.002) and constipated women (5 ± 9 mm Hg, P = 0.004). After relaxation, anal pressure declined (P = 0.0004) by 3 ± 4 mm Hg in DD patients but not in controls. Alfuzosin reduced (P = 0.0001) anal resting pressure (by 31 ± 19 mm Hg) vs placebo (16 ± 18 mm Hg). However, during the postdrug Stroop test, anal pressure increased (P = 0.0001) in participants who received alfuzosin but not placebo. Conclusions & Inferences: In healthy controls and DD patients, mental stressors likely increased anal pressure by contracting the internal anal sphincter; relaxation reduced anal pressure in DD patients. Alfuzosin reduced anal resting pressure but did not block the Stroop-mediated contractile response, which suggests that this response is not entirely mediated by adrenergic α 1 receptors.

AB - Background: Our aim is to explain the lack of clarity in the ways in which anxiety and depression, which are common in defecatory disorders (DD), may contribute to the disorder. In this study, we evaluate the effects of mental stress and relaxation on anal pressures and the mechanisms thereof. Methods: In 38 healthy women and 36 DD patients, rectoanal pressures were assessed at rest and during mental stressors (ie, word-color conflict [Stroop] and mental arithmetic tests) and mental relaxation, before and after randomization to placebo or the adrenergic α 1 -antagonist alfuzosin. Key Results: During the baseline Stroop test, the anal pressure increased by 6 ± 13 mm Hg (mean ± SD, P = 0.004) in healthy women and 9 ± 10 mm Hg (P = 0.0001) in constipated women. During mental arithmetic, the anal pressure increased in healthy (4 ± 8 mm Hg, P = 0.002) and constipated women (5 ± 9 mm Hg, P = 0.004). After relaxation, anal pressure declined (P = 0.0004) by 3 ± 4 mm Hg in DD patients but not in controls. Alfuzosin reduced (P = 0.0001) anal resting pressure (by 31 ± 19 mm Hg) vs placebo (16 ± 18 mm Hg). However, during the postdrug Stroop test, anal pressure increased (P = 0.0001) in participants who received alfuzosin but not placebo. Conclusions & Inferences: In healthy controls and DD patients, mental stressors likely increased anal pressure by contracting the internal anal sphincter; relaxation reduced anal pressure in DD patients. Alfuzosin reduced anal resting pressure but did not block the Stroop-mediated contractile response, which suggests that this response is not entirely mediated by adrenergic α 1 receptors.

KW - alfuzosin

KW - anal pressure

KW - constipation

KW - mental stressors

KW - Stroop

UR - http://www.scopus.com/inward/record.url?scp=85065162997&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065162997&partnerID=8YFLogxK

U2 - 10.1111/nmo.13618

DO - 10.1111/nmo.13618

M3 - Article

JO - Neurogastroenterology and Motility

JF - Neurogastroenterology and Motility

SN - 1350-1925

M1 - e13618

ER -